Development of the Angioedema Control Test-A patient-reported outcome measure that assesses disease control in patients with recurrent angioedema.

Karsten WellerTamara DonosoMarkus MagerlEmel Aygören-PürsünPetra StaubachInmaculada Martinez-SaguerTomasz HawroSabine Altrichter Karoline Krause Frank Siebenhaar Martin Metz Torsten ZuberbierDenise FreierMarcus Maurer

Published in: Allergy (2020)

The AECT is the first tool to assess disease control in recurrent AE patients. Its retrospective approach, its brevity and its simple scoring make the AECT ideally suited for clinical practice and trials. Its validity and reliability need to be determined in future independent studies.

Keyphrases

patient reported outcomes
clinical practice
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported